Meta AnalysisID 4637

尿素治疗不适当抗利尿激素分泌综合征

CRD42021213569

What is the currently available evidence for or against urea for hyponatremia from syndrome of inappropriate antidiuretic hormone secretion?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
4637
Evidence Id
13195
Core Evidence Id
13195
Source Meta Analysis Id
4666
Herb2 Meta Analysis Id
HBMA004666
Crd Id
CRD42021213569
Title
Urea for Syndrome of Inappropriate Antidiuretic Hormone Secretion
Review Question
What is the currently available evidence for or against urea for hyponatremia from syndrome of inappropriate antidiuretic hormone secretion?
Study Type Included
Inclusion criteria: -One of the treatments is oral urea -Patient cohort or subgroup consists of close to 100% hyponatremic patients with a presumed etiology of SIADH -Full-length manuscripts, research letters/brief reports, abstracts/conference proceedings describing original studies (retro- or prospective incl. observational and trial, open and blinded, and case report or series) -Reviews will be searched for references -Any or no comparator -Endpoints: plasma or serum sodium level; osmotic demyelination syndrome; resource use, e.g., length of stay or costs (or component of either) Exclusion criteria: -Language not English, French, or German -One of the treatments is not consist of only (or close to 100%) hyponatremic patients with a presumed etiology of SIADH -Patient cohort or subgroup does not consist of only (or close to 100%) hyponatremic patients with a presumed etiology of SIADH -None of the endpoints match our desired ones - 100% (or near 100%) pediatric patients -Language other than English, French, or German
Condition Being Studied
Syndrome of Inappropriate Antidiuretic Hormone Secretion
Participant
Patients with acute moderate to severe hyponatremia, defined as a serum sodium of <130 mEq/L, where the etiology is believed to be syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Animal
Human Disease Modelled
Intervention
Urea
Comparator Control
1) nonpeptide vasopressin receptor antagonists (vaptans); 2) supportive measures (e.g., treating the underlying disease; fluid restriction; sodium administration with or without a loop diuretic; or demeclocycline or lithium)
Main Outcome
-Plasma or serum sodium level Measures of effect -Standardized mean difference of sodium level
Outcome Measure
Additional Outcome
-Occurrence of severe adverse events-Occurrence of osmotic demyelination syndrome or other severe adverse events -Resource use, e.g., length of stay or costs (or component of either) -Cost-effectiveness Measures of effect -Relative risk of severe adverse events -Relative risk of osmotic demyelination syndrome -Standardized mean difference of sodium level -Standardized mean difference of costs -Incremental cost-effectiveness ratio
Study Method
Intervention, Systematic review
Keyword
Bodily Secretions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Urea; Vasopressins
Contact
Benjamin Geisler [email protected]
Organisational Affiliation
Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig Maximilian University, Munich https://www.ibe.med.uni-muenchen.de/index.html
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Germany
Review Stage
Review Ongoing
First Submission Date
2020-10-09
Registration Date
2021-01-11
Anticipated Start Date
2019-10-10
Anticipated Completion Date
2021-04-30
Title Cn
尿素治疗不适当抗利尿激素分泌综合征
Title En
Urea for Syndrome of Inappropriate Antidiuretic Hormone Secretion
Bilingual Status
complete